Crossroads Cancer Center is a clinical research site located in Effingham, Illinois, United States 62401.
Crixeo Health Trust Score: 90/100 (GOOD). This profile has not yet been claimed by the site owner.
Crossroads Cancer Center has participated in 409 clinical trials with 276 currently active.
Therapeutic areas: Ovarian Granulosa Cell Tumor, Ovarian Gynandroblastoma, Ovarian Sertoli-Leydig Cell Tumor.
Sponsors: GOG Foundation, SWOG Cancer Research Network, CTI BioPharma.
Trust Score: 90/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Crossroads Cancer Center has a Crixeo Trust Score of 90/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Crossroads Cancer Center has 409 clinical trials on record, with 276 currently active. Their work covers Ovarian Granulosa Cell Tumor, Ovarian Gynandroblastoma, Ovarian Sertoli-Leydig Cell Tumor.
Crossroads Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.